Leute, schaut mal wer sich da alles aus der CRC für ProColon ausspricht und vergleicht das mit einem Absatz aus der aktuellen ppt. S. 17
Tier 1 Code:
In their panel meeting in February 2016, the CPT Editorial Panel of the American Medical Association decided to issue a test specific, tier 1 CPT code for methylated Septin9 for analysis of colorectal cancer (813X7)
Cross-walk submitted to CMS for $159 per test reimbursement
Cross-walk proposal formally supported by AMP, AACC, AMA, and CAP
Expected determination in October 2016
Es sind Sprecher und Vorstände einiger Organisationen, die den Cross-walk für die Erstattung unterstützen.
The panel entitled "Screening the Unscreened: New Approaches to Reaching
the Underserved to Prevent Colorectal Cancer" included leading experts
within the Colorectal Cancer and gastroenterology community:
Hier AMP
"Death from colorectal cancer is preventable if caught early," said Jeffrey
Cossman, M.D., Founder of United States Diagnostic Standards, Inc. (USDS)
and Association for Molecular Pathology (AMP). "But despite decades of our
best efforts, still 1 in 3 or almost 23 million Americans are not screened.
A new, cost-effective DNA blood-test for colorectal cancer screening is a
unique opportunity to overcome existing testing barriers and disparities.
There is overwhelming evidence that underserved and rural populations
suffer most from low colorectal cancer screening rates."
Wichtiger Vertreter der Gastroenterologen
"There is clear evidence that lack of colorectal cancer screening results
in a higher incidence of late-stage colorectal cancer disproportionately in
ethnic minorities," said Amar R. Deshpande, M.D., Vice Chief for Education,
Division of Gastroenterology (Department of Medicine), University of Miami.
"A patient accepted blood test covered under Medicare could benefit these
communities and thereby reduce the number of related deaths."
Hier ist es ein grosser Multiplikator "Geisinger" leading Hospitals/ Heath care provider
"As a practicing primary care physician, the importance of regular
colorectal cancer screening cannot be overemphasized," said Raymond
Nungesser, M.D., Family Medicine Practitioner, Geisinger Health System.
"Unfortunately, barriers exist for many of my rural patients. A blood test
for colorectal cancer screening addresses those barriers and provides
medical professionals with a new tool in the fight against one of the
deadliest cancers in the United States."
Verband der Labornetzwerke. Potter hat die PRESEPT Studie für ProColon geleitet:
"The advances in molecular diagnostics have provided us with a disruptive
technology to reach the 1 in 3 who have avoided colorectal cancer
screening," said Nicholas Potter, PhD., Executive Vice-President of
Clinical Affairs, Molecular Pathology Laboratory Network. "The introduction
of a novel DNA blood test has the potential to increase compliance with
colorectal cancer screening, as demonstrated in clinical studies."
Großer CRC Dachverband, der die 80% erreichen will:
"We are extremely pleased by Congressman Donald Payne's colorectal cancer
screening initiative," said Michael Sapienza, Chief Executive Officer, The
Colon Cancer Alliance. "Improving access to new technologies for colorectal
cancer screening will contribute to reaching 80% screening rates by 2018
and to fulfilling our mission of ultimately knocking out colorectal
cancer."
Also ich glaube das ist besser, als 40 Mio USD für TV Werbung auszugeben (Exas). Wenn man bedenkt, dass das Thema Erstattung für ProColon und wie weit der Kongress damit gekommen ist öfter mal in den Nachrichten kommt und so US Zuschauer erreicht, die noch nie von einem CRC Bluttest gehört haben.
Leute, das ist seriöse Werbung für Umme. Besser kann es nicht laufen für uns. Hamilton macht gute Arbeit im Hintergrund. |
Thread abonnieren
